Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Pooja Advani,1 Lauren Cornell,2 Saranya Chumsri,1 Alvaro Moreno-Aspitia1 1Division of Hematology and Oncology, 2Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA Abstract: Human epidermal growth factor receptor 2 (HER2) is a tyrosine kinase transmembrane receptor that is overexpre...

Full description

Saved in:
Bibliographic Details
Main Authors: Advani P, Cornell L, Chumsri S, Moreno-Aspitia A
Format: article
Language:EN
Published: Dove Medical Press 2015
Subjects:
Online Access:https://doaj.org/article/308bd5693bff4d35aae88c3b548279a8
Tags: Add Tag
No Tags, Be the first to tag this record!